Skip to content

Cardinal Health

US · CAH #429 by market cap Listed 1970
272.81 +0.47 +0.17%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Rating change
    H.U. Group Holdings Posts Strong Profit Rebound and Maintains Dividend Guidance
    TipRanks · 2026/8/12
  • Rating change
    U.S. Stocks Movement | Huazhu Group’s ADRs rose 2.6% pre-market, while its H shares closed up 5.56% today. Morgan Stanley raised its target price to $47.
    Gelonghui Finance · 2025/11/10
  • Rating change
    H.C. Wainwright Maintains U.S. Goldmining(USGO.US) With Buy Rating, Raises Target Price to $30.75
    Market Newswire · 2026/3/3
  • Company notice
    H U Group Holdings: Blood-Based β-Amyloid 1-42 IVD Test Approved in Japan to Help Assess Amyloid β Accumulation in the Brain Associated with Alzheimer's Disease
    JPX · 2026/11/18
  • Rating change
    H.C. Wainwright Maintains U.S. Goldmining(USGO.US) With Buy Rating, Maintains Target Price $26.5
    Market Newswire · 2026/1/14
  • Company notice
    H U Group Holdings: H.U. Group Holdings Integrated Report 2026
    JPX · 2026/11/18
  • Rating change
    H.C. Wainwright Maintains U.S. Gold Corp(USAU.US) With Buy Rating, Maintains Target Price $27.5
    Market Newswire · 2026/9/22
  • Rating change
    UBS Maintains H.U. GROUP HLDGS INC(MRCHF.US) With Buy Rating, Cuts Target Price to $23.98
    Market Newswire · 2026/5/28
  • Rating change
    H.C. Wainwright Maintains U.S. Goldmining(USGO.US) With Buy Rating, Maintains Target Price $30.75
    Market Newswire · 2026/10/31
  • Company notice
    H U Group Holdings: Regarding the acquisition of manufacturing and marketing approval in Japan for a blood-based β-amyloid 1–42 assay reagent that assists in assessing the accumulation of brain amyloid β associated with Alzheimer's disease.
    JPX · 2026/11/18
  • Rating change
    UBS Upgrades H.U. GROUP HLDGS INC(MRCHF.US) to Buy Rating, Raises Target Price to $28.62
    Market Newswire · 2026/2/12
  • Company notice
    H U Group Holdings: Blood-Based pTau217 IVD Test Approved in Japan to Help Assess Amyloid β Accumulation in the Brain Associated with Alzheimer's Disease
    JPX · 2026/11/11
  • Rating change
    H.C. Wainwright Maintains U.S. Gold Corp(USAU.US) With Buy Rating, Raises Target Price to $27.5
    Market Newswire · 2026/1/7
  • Rating change
    CLSA: Maintains "Outperform" rating and HK$262 target price for Wuxi Apptec (02359) following its removal from the U.S. Section 1260H list
    Zhitong Finance · 2026/11/10
  • Company notice
    H U Group Holdings: Interim Report – Fiscal Year 77 (April 1, 2026 – March 31, 2027)
    EDINET · 2026/11/13
  • U M H PROPERTIES INC 6.375% CUM RED PREF SHS SER D USD25 To Go Ex-Dividend On November 16th, 2026 With 0.39844 USD Dividend Per Share
    Market Newswire · 2026/11/13
  • Wuxi Apptec (603259): U.S. Department of Defense removes the company from the Section 1260H list, significantly reducing geopolitical risks
    China Merchants Securities · 2026/11/13
  • Is U.S. tech talent beginning to flee? As H-1B visa restrictions tighten, highly skilled workers are seeking alternative pathways.
    wallstreetcn · 2026/11/20
  • U.S. H-1B visa issuances drop by approximately one-third year-on-year as companies such as IBM reduce sponsorship for foreign employees
    cls.cn · 2026/11/21
  • KORE US REIT: 2H 2026, 1H 2027 Distribution Per Unit Expected to Remain Consistent at 0.40 U.S. Cents CMOU.SG
    Dow Jones · 2026/10/27
  • Company notice
    H U Group Holdings: Notice Regarding the Status of Treasury Stock Acquisitions
    JPX · 2026/10/1
  • Rating change
    H.C. Wainwright Maintains U.S. Gold Corp(USAU.US) With Buy Rating, Raises Target Price to $22
    Market Newswire · 2025/9/25
  • U Power 1H Rev $2.2M UCAR
    Dow Jones · 2026/11/7
  • U Power 1H Loss $8.1M UCAR
    Dow Jones · 2026/11/7
  • U.S. Visa Storm Hits! Microsoft and Other Tech Firms Face Blocked H-1B and Green Card Pathways; Nine Elite Universities Including Harvard Under Fraud Investigation
    wallstreetcn · 2026/10/9

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:34 · For reference only, not investment advice and not tailored to your situation.

Cardinal Health discussion 0 comments

Add a comment